Automated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 51, 2014, Pages 18249-18254

  Kumar, Aparna ^a   Rao, Arvind ^a,d   Bhavani, Santosh ^a   Newberg, Justin Y ^b,c,e   Murphy, Robert F ^a,b,c  

^a Carnegie Mellon University   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Biomarkers; Cancer; Digital pathology; Image analysis; Protein subcellular location

Indexed keywords

BETA CATENIN; BTNL2 PROTEIN; ECE1 PROTEIN; FAM120A PROTEIN; FGFR10P2 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METTL21A PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 12; NT5DC3 PROTEIN; PSTPIP2 PROTEIN; RASGRF2 PROTEIN; SCRN2 PROTEIN; SLC30A9 PROTEIN; TMEM194A PROTEIN; TTC27 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; USP10 PROTEIN; UVOMORULIN; WDR24 PROTEIN; TUMOR PROTEIN;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER GRADING; IMMUNOHISTOCHEMISTRY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; AUTOMATION; CELL FRACTIONATION; HUMAN; METABOLISM; NEOPLASM;

AUTOMATION; BIOMARKERS, TUMOR; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; SUBCELLULAR FRACTIONS;

EID: 84919941278     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1415120112     Document Type: Article

References (28)

1. Kononen J, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4(7):844-847.
2. Khan J, et al. (1999) Expression profiling in cancer using cDNA microarrays. Electrophoresis 20(2):223-229.
3. Mardis ER, Wilson RK (2009) Cancer genome sequencing: A review. Hum Mol Genet 18(R2):R163-R168.
4. Leung F, Diamandis EP, Kulasingam V (2012) From bench to bedside: Discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade. Biomarkers Med 6(5):613-625.
5. Chung GG, et al. (2001) Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res 7(12):4013-4020.
6. Lessard L, et al. (2006) Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res 12(19):5741-5745.
7. Guillaud M, et al. (2005) Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV. Gynecol Oncol 99(3, suppl 1):S16-S23.
8. Shariff A, Kangas J, Coelho LP, Quinn S, Murphy RF (2010) Automated image analysis for high-content screening and analysis. J Biomol Screen 15(7):726-734.
9. Lejeune M, et al. (2008) Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: Validation of a new computer-assisted image analysis procedure. J Anat 212(6):868-878.
10. Matos LL, Trufelli DC, de Matos MG, da Silva Pinhal MA (2010) Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights 5:9-20.
11. Newberg J, Murphy RF (2008) A framework for the automated analysis of subcellular patterns in Human Protein Atlas images. J Proteome Res 7(6):2300-2308.
12. Glory E, Newberg J, Murphy RF (2008) Automated comparison of protein subcellular location patterns between images of normal and cancerous tissues. Proc IEEE Int Symp Biomed Imaging 2008:304-307.
13. Uhlén M, et al. (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4(12):1920-1932.
14. Fitzgerald LM, et al. (2013) Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility. Cancer Epidemiol Biomarkers Prev 22(9):1520-1528.
15. Chitu V, et al. (2009) Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice. Blood 114(12):2497-2505.
16. Yuan J, Luo K, Zhang L, Cheville JC, Lou Z (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140(3):384-396.
17. Yelamos J, Farres J, Llacuna L, Ampurdanes C, Martin-Caballero J (2011) PARP-1 and PARP-2: New players in tumour development. Am J Cancer Res 1(3):328-346.
18. Mahapatra S, et al. (2012) Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res 18(10):2882-2895.
19. Lambert LA, Whyteside AR, Turner AJ, Usmani BA (2008) Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion. Br J Cancer 99(7):1114-1120.
20. Massoner P, et al. (2013) Characterization of transcriptional changes in ERG re-arrangement- positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y. PLoS ONE 8(2):e55207.
21. Matsuoka M, Jeang KT (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7(4):270-280.
22. Xu X, Chen J (2009) One-carbon metabolism and breast cancer: An epidemiological perspective. J Genet Genomics 36(4):203-214.
23. Howe LR, Brown PH (2011) Targeting the HER/EGFR/ErbB family to prevent breast cancer. Cancer Prev Res (Phila) 4(8):1149-1157.
24. Ito H, et al. (2006) Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin Cancer Res 12(11 pt 1):3257-3264.
25. Biankin AV, et al.; Australian Pancreatic Cancer Genome Initiative (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491(7424):399-405.
26. Kimbro KS, Simons JW (2006) Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 13(3):739-749.
27. Collett GP, et al. (2000) Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma. Clin Cancer Res 6(8):3241-3248.
28. Barron DA, Kagey JD (2014) The role of the Hippo pathway in human disease and tumorigenesis. Clin Ttransl Med 3:25.